Abstract:BACKGROUND: Growing animal evidence demonstrates that prolonged exposure to propofol during brain development induces widespread neuronal cell death, but there is little information on the role of astrocytes. Astrocytes can release neurotrophic growth factors such as brain-derived neurotrophic factor (BDNF), which can exert the protective effect on neurons in paracrine fashion. We hypothesize that during propofol anesthesia, BDNF released from developing astrocytes may not be sufficient to prevent propofol-induced neurotoxicity. METHODS: Hippocampal astrocytes and neurons isolated from neonatal Sprague Dawley rats were exposed to propofol at a clinically relevant dose of 30 &mgr;M or dimethyl sulfoxide as control for 6 hours. Propofol-induced cell death was determined by propidium iodide (PI) staining in astrocyte-alone cultures, neuron-alone cultures, or cocultures containing either low or high density of astrocytes (1:9 or 1:1 ratio of astrocytes to neurons ratio [ANR], respectively). The astrocyte-conditioned medium was collected 12 hours after propofol exposure and measured by protein array assay. BDNF concentration in astrocyte-conditioned medium was quantified using enzyme-linked immunosorbent assay. Neuron-alone cultures were treated with BDNF, tyrosine receptor kinase B inhibitor cyclotraxin-B, glycogen synthase kinase 3&bgr; (GSK3&bgr;) inhibitor CHIR99021, or mitochondrial fission inhibitor Mdivi-1 before propofol exposure. Western blot was performed for quantification of the level of protein kinase B and GSK3&bgr;. Mitochondrial shape was visualized through translocase of the outer membrane 20 staining. RESULTS: Propofol increased cell death in neurons by 1.8-fold (% of PI-positive cells [PI%] = 18.6; 95% confidence interval [CI], 15.2–21.9, P < .05) but did not influence astrocyte viability. The neuronal death was attenuated by a high ANR (1:1 cocultures; fold change [FC] = 1.17, 95% CI, 0.96–1.38, P < .05), but not with a low ANR [1:9 cocultures; FC = 1.87, 95% CI, 1.48–2.26, P > .05]). Astrocytes secreted BDNF in a cell density-dependent way and propofol decreased BDNF secretion from astrocytes. Administration of BDNF, CHIR99021, or Mdivi-1 significantly attenuated the propofol-induced neuronal death and aberrant mitochondria in neuron-alone cultures (FC = 0.8, 95% CI, 0.62–0.98; FC = 1.22, 95% CI, 1.11–1.32; FC = 1.35, 95% CI, 1.16–1.54, respectively, P < .05) and the cocultures with a low ANR (1:9; FC = 0.85, 95% CI, 0.74–0.97; FC = 1.08, 95% CI, 0.84–1.32; FC = 1.25, 95% CI, 1.1–1.39, respectively, P < .05). Blocking BDNF receptor or protein kinase B activity abolished astrocyte-induced neuroprotection in the cocultures with a high ANR (1:1). CONCLUSIONS: Astrocytes attenuate propofol-induced neurotoxicity through BDNF-mediated cell survival pathway suggesting multiple neuroprotective strategies such as administration of BDNF, astrocyte-conditioned medium, decreasing mitochondrial fission, or inhibition of GSK3&bgr;.

Propofol Rescued Astrocytes from LPS-induced Inflammatory Response Via Blocking LncRNA-MEG3/NF-κB Axis

Propofol Inhibits Microglial Activation Via Mir-106B/pi3k/akt Axis.

Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway

Delayed Treatment of Propofol Inhibits Lipopolysaccharide-Induced Inflammation in Microglia Through the PI3K/PKB Pathway.

Propofol Reduces Microglia Activation and Neurotoxicity Through Inhibition of Extracellular Vesicle Release

Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia

Propofol pretreatment attenuates glutamate induced excitotoxicity of astrocytes via the p90RSK / Bcl-2 signaling pathway

Propofol Attenuates Inflammatory Damage <i>via</i> Inhibiting NLRP1-Casp1-Casp6 Signaling in Ischemic Brain Injury

Overexpression of miR-221-3p effecting cell proliferation, apoptosis and inflammation by targeting Toll-like receptors 4 in propofol-induced rat astrocytes

Propofol Attenuates Intermittent Hypoxia Induced Up-Regulation of Proinflammatory Cytokines in Microglia Through Inhibiting the Activation of NF-Bκ/p38 MAPK Signalling.

Propofol Prevents Cerebral Ischemia-Triggered Autophagy Activation and Cell Death in the Rat Hippocampus Through the NF-κB/p53 Signaling Pathway

Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis

Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling

Propofol Ameliorates Spinal Cord Injury Process by Mediating miR-672-3p/TNIP2 Axis

Effects of propofol against LPS-induced inflammation injury of Ana-1 cells

Propofol Pretreatment Prevents Oxygen-Glucose Deprivation/Reoxygenation (OGD/R)-induced Inflammation Through Nuclear Transcription Factor κB (NF-κB) Pathway in Neuroblastoma Cells

Insufficient Astrocyte-Derived Brain-Derived Neurotrophic Factor Contributes to Propofol-Induced Neuron Death Through Akt/Glycogen Synthase Kinase 3β/mitochondrial Fission Pathway.

Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo

Inhibition of the NLRP3/caspase-1 cascade related pyroptosis relieved propofol-induced neuroinflammation and cognitive impairment in developing rats

Inhibition of Microglial Activation Contributes to Propofol-Induced Protection Against Post-Cardiac Arrest Brain Injury in Rats

[Effect of Propofol on the Activation of Nuclear Factor-Kappa B and Expression of Inflammatory Cytokines in Cerebral Cortex During Transient Focal Cerebral Ischemia-Reperfusion: Experiment with Rats].